| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C0038333> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C0043481> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C0073096> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C0085104> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C0664965> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C1101322> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C1258633> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C1450054> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C1721058> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C2002402> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C2930481> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C4508800> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33894625_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Pharmacology Department, College of Medicine, Minia University, Egypt. Electronic address: drthabetpharm@yahoo.com.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Kelleni_Mina_T>
?:doi	S0753-3322(21)00411-X10.1016/j.biopha.2021.111626
?:doi	<https://research.tib.eu/covid-19/entity/S0753-3322%2821%2900411-X10.1016/j.biopha.2021.111626>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33894625>
?:pmid	<https://research.tib.eu/covid-19/entity/33894625>
?:pmid	33894625
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Resveratrol-zinc nanoparticles or pterostilbene-zinc: Potential COVID-19 mono and adjuvant therapy.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33894625>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33894625>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all